Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 7,10 M
EBIT 2016 -8,60 M
Net income 2016 -8,50 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -
Net income 2017 -
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 -
Capi. / Sales 2016 8,60x
Capi. / Sales 2017 -
Capitalization 61,1 M
More Financials
Company
Aviragen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening infectious diseases.The Company currently has two Phase 2 clinical-stage product candidates in development: laninamivir... 
More about the company
Latest news on BIOTA PHARMACEUTICALS INC
05/09 AVIRAGEN THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fin..
05/06 AVIRAGEN THERAPEUTICS : Biota reports 3Q loss
05/05 Aviragen Therapeutics Reports Third Quarter Fiscal Year 2016 Financial Result..
05/05 AVIRAGEN THERAPEUTICS : Reports Third Quarter Fiscal Year 2016 Financial Results
04/28 Aviragen Therapeutics to Host Conference Call to Report Third Quarter Fiscal ..
04/26 AVIRAGEN THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other ..
04/25 Aviragen Therapeutics Completes Royalty Deal With HealthCare Royalty Partners..
2012 NABI BIOPHARMACEUTICALS : Effects Reverse Stock Split and Announces the Completi..
More news
Sector news : Bio Therapeutic Drugs
06:16aDJREGENERON PHARMACEUTICALS : Named as Science Talent Search Sponsor
01:10a AMGEN : Announces Early Tender Results Of Senior Notes Exchange Offers
05/25 GILEAD SCIENCES : Announces Appointment of Kevin Young CBE as Chief Operating Of..
More sector news : Bio Therapeutic Drugs
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions